MarketResearch.com logo

Recent Multiple Sclerosis (MS) Research for May 2017


China Interferon Industry Report, 2016-2021
Topics: Research & Development, Hepatitis, Multiple Sclerosis (MS)
Regions: China
Global Multiple Sclerosis Partnering 2010 to 2017
Topics: Multiple Sclerosis (MS)
Regions: Global
Multiple Sclerosis - Pipeline Review, H2 2016
Topics: Multiple Sclerosis (MS), Drug Discovery
Overcoming Market Access Barriers to High Value Drugs
Topics: AIDS, HIV & STDs, Multiple Sclerosis (MS), Prescription Drugs
Global Multiple Sclerosis (MS) Therapeutics Market Research Report 2017
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
Progressive Relapsing Multiple Sclerosis (PRMS) - Pipeline Review, H2 2016
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Primary Progressive Multiple Sclerosis (PPMS)-Pipeline Insights, 2016
Topics: Multiple Sclerosis (MS)
Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights, 2016
Topics: Multiple Sclerosis (MS)
Market Access Impact: Multiple Sclerosis (EU5)
Topics: Multiple Sclerosis (MS)
Market Access Impact: Multiple Sclerosis (US)
Topics: Multiple Sclerosis (MS)
Regions: United States
Global Primary Progressive Multiple Sclerosis Market Research Report 2016
Topics: Multiple Sclerosis (MS)
Regions: Global
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016
Topics: Multiple Sclerosis (MS), Drug Discovery
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2016
Topics: Multiple Sclerosis (MS), Drug Discovery
Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Medical Affiars Reputation: Multiple Sclerosis (EU5)
Topics: Multiple Sclerosis (MS)
Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2016
Topics: Multiple Sclerosis (MS)
Relapsing Remitting Multiple Sclerosis (RRMS)-Pipeline Insights, 2016
Topics: Multiple Sclerosis (MS)
Medical Affiars Reputation: Multiple Sclerosis (US)
Topics: Multiple Sclerosis (MS)
Regions: United States
Multiple Sclerosis Drugs Market and R&D Outlook 2016-2026
Topics: Multiple Sclerosis (MS)
Multiple Sclerosis: Payer Insight
Topics: Multiple Sclerosis (MS)
Neurorehabilitation Devices Market By Products (Neurorobotics, Brain-Computer Interface, Wearable Devices, Noninvasive Stimulators), By Therapy Area (Stroke, Multiple Sclerosis, Parkinson’s Disease, Cerebral Palsy, Others - Brain And Spinal Cord Injury),
Topics: Parkinson's Disease, Multiple Sclerosis (MS), Neurology Devices
Global Primary Progressive Multiple Sclerosis Market Report 2016
Topics: Multiple Sclerosis (MS)
Regions: Global
Multiple Sclerosis Global Clinical Trials Review, H2, 2016
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
U.S. Therapeutic Plasma Exchange Market by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Guillain Barre Syndrome, Multiple Sclerosis, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - Forecasts to 202
Topics: Instrumentation & Equipment, Autoimmune, Multiple Sclerosis (MS), CNS/Neurology
Regions: United States
Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2016
Topics: Multiple Sclerosis (MS), Drug Discovery
Multiple Sclerosis - US Drug Forecast and Market Analysis to 2024
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Regions: United States
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2015
Topics: Multiple Sclerosis (MS), Drug Discovery
Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2024
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Regions: Canada
Multiple Sclerosis Pipeline Highlights – 2015 Update
Topics: Multiple Sclerosis (MS), Manufacturing, Packaging & Detailing, Drug Discovery
Japan Multiple Sclerosis Market Highlights – 2015
Topics: Multiple Sclerosis (MS)
Regions: Japan
US Multiple Sclerosis Market Highlights – 2015
Topics: Multiple Sclerosis (MS)
Regions: United States
Multiple Sclerosis Pipeline Highlights – 2016
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2016
Topics: Multiple Sclerosis (MS)
Regions: Global
The National Multiple Sclerosis Society – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Topics: General Company Reports, Multiple Sclerosis (MS)
Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2015
Topics: Multiple Sclerosis (MS), Drug Discovery
Multiple Sclerosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Topics: Multiple Sclerosis (MS), Prescription Drugs
Regions: Global
Multiple Sclerosis Market in the US 2015-2019
Topics: Multiple Sclerosis (MS), Research & Development
Regions: United States
Italy Multiple Sclerosis Market and Competitive Landscape Highlights – 2016
Topics: Multiple Sclerosis (MS)
Regions: Italy
Multiple Sclerosis: Update Bulletin [March 2016]
Topics: Multiple Sclerosis (MS)
Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H2, 2015
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
NPS+ Multiple Sclerosis (US)
Topics: Multiple Sclerosis (MS)
Regions: United States
Multiple Sclerosis - China Drug Forecast and Market Analysis to 2024
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Regions: China
Medical Affairs Reputations (EU5): Multiple Sclerosis
Topics: Multiple Sclerosis (MS), Physicians' Offices
Regions: France, Germany, Italy, Spain, United Kingdom
Multiple Sclerosis - 5EU Drug Forecast and Market Analysis to 2024
Topics: Multiple Sclerosis (MS)
Multiple Sclerosis - India Drug Forecast and Market Analysis to 2024
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Regions: India
Multiple Sclerosis - Current and Future Players
Topics: Multiple Sclerosis (MS)
PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2024
Topics: Multiple Sclerosis (MS)
Regions: Global
Relapsing Multiple Sclerosis (RMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Topics: Multiple Sclerosis (MS)
Regions: Global
Relapsing Remitting Multiple Sclerosis (RRMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Topics: Multiple Sclerosis (MS)
Regions: Global


Prev  | 1  | 2  | 3  | Next    

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.